Equities Research Analysts’ downgrades for Tuesday, April 23rd:
Abeona Therapeutics (NASDAQ:ABEO) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Addus HomeCare (NASDAQ:ADUS) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. The firm currently has $83.00 target price on the stock.
Canadian Natural Resources (NYSE:CNQ) (TSE:CNQ) was downgraded by analysts at Desjardins from a buy rating to a hold rating.
Cooper-Standard (NYSE:CPS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Escalade (NASDAQ:ESCA) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Five Below (NASDAQ:FIVE) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $170.00 target price on the stock, down from their previous target price of $215.00.
First Merchants (NASDAQ:FRME) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
FRP (NASDAQ:FRPH) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
International Business Machines (NYSE:IBM) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
MP Materials (NYSE:MP) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $16.00 target price on the stock, down from their previous target price of $20.00.
Sunnova Energy International (NYSE:NOVA) was downgraded by analysts at KeyCorp from an overweight rating to a sector weight rating.
Park Hotels & Resorts (NYSE:PK) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
SunPower (NASDAQ:SPWR) was downgraded by analysts at Evercore ISI from an outperform rating to an inline rating. Evercore ISI currently has $6.00 target price on the stock.
Warner Bros. Discovery (NASDAQ:WBD) was downgraded by analysts at Wolfe Research from a peer perform rating to an underperform rating. The firm currently has $7.00 target price on the stock.
Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.